FDA Inspection
VitalantVitalant – FDA Inspection, Apr 30, 2015
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on April 30, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- April 30, 2015
- Product Type
- Biologics
View Company Profile
ID · 61b9e299-b13c-4e4b-b5a8-2a484f0a7de7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 924066
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2025 | Not classified | Seattle District Office | |
| September 24, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 20, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 8, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 26, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1277492 - 2025-07-18
- FDA Inspection 1154344 - 2021-09-24
- FDA Inspection 1106094 - 2019-09-20
- FDA Inspection 1011386 - 2017-05-08
- FDA Inspection 837856 - 2013-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.